Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

被引：0
作者：
Benaim, EA
Page, CM
Lam, PM
Roehrborn, CG
机构：
[1] Univ Texas, SW Med Ctr, Dept Urol, Dallas, TX USA
[2] N Texas Vet Affairs Hlth Care Ctr, Dallas, TX USA
来源：
JOURNAL OF UROLOGY | 2002年 / 168卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：379 / 379
页数：1
相关论文
共 50 条
[21]   The change in free-to-total prostate-specific antigen during progression to androgen-independent state in prostate cancer patients: utilization for intermittent androgen suppression therapy [J].
Akakura, K .
PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (Suppl 3) :S2-S2
[22]   Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression [J].
Perner, SR ;
Hofer, MD ;
Li, H ;
Kuefer, R ;
Gschwend, J ;
Hautmann, R ;
Moeller, P ;
Rubin, MA .
LABORATORY INVESTIGATION, 2006, 86 :155A-155A
[23]   Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression [J].
Perner, SR ;
Hofer, MD ;
Li, H ;
Kuefer, R ;
Gschwend, J ;
Hautmann, R ;
Moeller, P ;
Rubin, MA .
MODERN PATHOLOGY, 2006, 19 :155A-155A
[24]   Prostate-specific membrane antigen (PSMA) expression as a predictor of prostate cancer progression [J].
Hofer, MD ;
Perner, S ;
Li, HJ ;
Kuefer, R ;
Hautmann, RE ;
Gschwend, JE ;
Moeller, P ;
Rubin, MA .
JOURNAL OF UROLOGY, 2006, 175 (04) :155-156
[25]   Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer [J].
Wagner, M ;
Garzotto, M ;
Lemmon, D ;
Eilers, KM ;
Beer, TM .
UROLOGY, 2005, 65 (04) :E37-E39
[26]   Prostate-specific antigen doubling time predicts response to deferred anti-androgen therapy in men with androgen-independent prostate cancer [J].
Shulman, MJ ;
Karam, JA ;
Benaim, EA .
UROLOGY, 2004, 63 (04) :732-736
[27]   Prostate-specific antigen decline pattern in advanced prostate cancer receiving androgen deprivation therapy and relationship with prostate-specific antigen progression [J].
Akbay, Erdem ;
Bozlu, Murat ;
Cayan, Selahittin ;
Kara, Pelin Ozcan ;
Tek, Mesut ;
Aytekin, Cuma .
AGING MALE, 2017, 20 (03) :175-183
[28]   Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells [J].
Blaszczyk, N ;
Masri, BA ;
Mawji, NR ;
Ueda, T ;
McAlinden, G ;
Duncan, CP ;
Bruchovsky, N ;
Schweikert, HU ;
Schnabel, D ;
Jones, EC ;
Sadar, MD .
CLINICAL CANCER RESEARCH, 2004, 10 (05) :1860-1869
[29]   Androgen-independent prostate cancer progression in the TRAMP model [J].
Gingrich, JR ;
Barrios, RJ ;
Kattan, MW ;
Nahm, HS ;
Finegold, MJ ;
Greenberg, NM .
CANCER RESEARCH, 1997, 57 (21) :4687-4691
[30]   Maximum tumor diameter is an independent predictor of prostate-specific antigen recurrence in prostate cancer [J].
Eichelberger, LE ;
Koch, MO ;
Eble, JN ;
Ulbright, TM ;
Juliar, BE ;
Cheng, L .
MODERN PATHOLOGY, 2005, 18 (07) :886-890
12345